Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|March 14, 2008
Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodiesEnver Akalin, Rajani Dinavahi, Rex Friedlander, et al.Blood|July 14, 2011
Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemiaSameer A Parikh, Michael J Keating, Susan O'Brien, et al.Cancer|May 16, 2006
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy aloneApostolia M Tsimberidou, Daniel Catovsky, Ellen Schlette, et al.Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphomaApostolia-Maria Tsimberidou, Sijin Wen, Peter McLaughlin, et al.Leukemia & Lymphoma|October 14, 2014
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomesOhad Benjamini, Preetesh Jain, Long Trinh, et al.British Journal of Haematology|November 10, 2009
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR)Gheath Alatrash, Maher Albitar, Susan O'Brien, et al.Blood|August 1, 2002
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Taghi Manshouri, et al.Clinical Transplantation|June 13, 2012
Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidatesVinay Nair, Deirdre Sawinski, Enver Akalin, et al.British Journal of Haematology|February 13, 2003
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemiaWilliam G Wierda, Marcella M Johnson, Kim-Anh Do, et al.Pageof 7